TokenPost·
AstraZeneca Reports Third-Quarter Core Earnings of $2.79 Per Share
Core earnings per share rose 19% at constant exchange rates. Oncology revenue increased 16% in the first nine months of 2026.
More news
- TokenPostLear Schedules Its Q3 Earnings Call for 9 a.m. ET on Oct. 30
- TokenPostMaine Student Says Data Center Protest Was Part of Political Internship
- TokenPostJinko Holdings Posts $2.03 Billion in Q3 Revenue, Down 10.6% Year Over Year
- CoinDeskHere's how big bitcoin traders responded after the Binance hack hit
- CryptoSlateBitcoin mining difficulty hits 148 trillion as revenues fall to three-month lows
- TokenPostBlockaid CEO Says Binance Attack Did Not Depend on EIP-7702